The Ottawa Hospital
Ottawa, Ontario, K1Y 4E9, Canada
NCT Number: NCT01423136
In moderate to high risk patients, cardiovascular complications after surgery account for almost 60% of death after surgery. This study will randomize 140 patients into routine postop care with Holter monitoring versus routine postop care + remote ST monitoring + Holter monitoring. The response time to electrocardiographic (ECG) ST changes as well as the total ischemia time will be studied.
Looking for future studies?
Notify Me55 year and older
All sexes
Observational
Ottawa, Ontario, K1Y 4E9, Canada
This proposal aims to improve the process and quality of care in the postoperative period by early detection of ischemia and prompt use of accepted therapies in order to prevent postoperative myocardial infarctions (PMI) in patients undergoing non-cardiac surgery. Specifically, it aims to validate the safety and efficacy of wireless remote real-time ECG ST-monitoring in the reduction of the incidence of PMI. It extends two pilot feasibility studies into the postoperative period using wireless remote ST-monitoring for early detection of myocardial ischemia followed by preventative strategies. It is anticipated that this research will improve postoperative care by adopting generalizable and practical strategies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
i. intermittent claudication (i.e. leg pain on walking that disappears in< 10 minutes on standing) that is known or likely to be due to atherosclerotic disease ii. an ankle/arm systolic BP ratio < 0.90 in either leg at rest iii. angiographic or Doppler study demonstrating >70% stenosis
Exclusion criteria
If ischemia noted, Sx will be notified and currently accepted treatments of myocardial ischemia will be recommended.
Time frame: 48 hours
To determine if the duration of postoperative myocardial ischemia during real-time wireless management of ischemic ECG ST changes is half that of standard postop care, as determined by 48-hour ambulatory ECG monitoring
Ottawa Hospital Research Institute
Other
Postop Remote ECG ST-Monitoring (PROSE 3)
Acronym: PROSE 3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03209674
Cardiac Complication, Cardiovascular Diseases
Neuilly-sur-Seine, Île-de-France Region, France
View Trial DetailsNCT04013360
Cardiac Complication, Complication, Postoperative
Santa Maria, Rio Grande do Sul, Brazil
View Trial DetailsNCT04501822
COVID-19, Cardiac Complication
Tyumen, Russia
View Trial DetailsNCT04063397
Cardiac Complication, Hemic and Lymphatic Diseases
Columbus, Ohio, United States
View Trial Details